Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma
| Autor: | Caitlin Costello, Edward D. Ball, Michelle Padilla, Carolyn Mulroney |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty business.industry Salvage therapy Daratumumab Phases of clinical research Hematology Pomalidomide medicine.disease Ixazomib chemistry.chemical_compound chemistry Internal medicine Relapsed refractory medicine business Dexamethasone Multiple myeloma medicine.drug |
| Zdroj: | Clinical Lymphoma Myeloma and Leukemia. 19:e360 |
| ISSN: | 2152-2650 |
| DOI: | 10.1016/j.clml.2019.09.595 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect